We showed for the rst time that comorbidities and CK were associated with a worse outcome independently of CLL-IPI, suggesting that comorbidities and CK might be considered as additional parameters to be included in CLL prognostic scores for better management of patients with CLL in clinical practice and in trials evaluating new drugs.
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI
Quaglia, Francesca Maria;
2017-01-01
Abstract
We showed for the rst time that comorbidities and CK were associated with a worse outcome independently of CLL-IPI, suggesting that comorbidities and CK might be considered as additional parameters to be included in CLL prognostic scores for better management of patients with CLL in clinical practice and in trials evaluating new drugs.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
